MYLIFE DIABETES CARE
LIVE

Serial Number

79437294

Owner

mylife Diabetes Care AG

Attorney

Joel D. Leviton

Filing Date

Jul 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MYLIFE DIABETES CARE Trademark

Serial Number: 79437294

MYLIFE DIABETES CARE is a trademark filed by mylife Diabetes Care AG on July 31, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently pending registration.

Owner Contact Info

mylife Diabetes Care AG

Lyssachstrasse 40

Entity Type: 98

TecMed AG (2 trademarks)

Technikumstrasse 2

Entity Type: 25

Trademark Details

Filing Date

July 31, 2025

Registration Date

Not Registered

Goods & Services

Medical services; health care

Printed handbooks in the field of self-medication, living with diabetes and handling of devices for self-medication, in particular insulin pumps; printed matter, namely, books, booklets, periodicals, journals and magazines in the field of self-medication, living with diabetes and handling of devices for self-medication, in particular insulin pumps; printed instructional or teaching material in the field of self-medication, living with diabetes and handling of devices for self-medication, in particular insulin pumps; printed club magazines intended for club members in the field of self-medication, living with diabetes and handling of devices for self-medication; printed journals in the field of lifestyles; printed journals in the field of health; printed journals in the field of events for people living with diabetes, for healthcare providers and for friends and relatives of people living with diabetes; printed medical information journals

Administering apparatus for medical or therapeutic self-medication in particular for treating diabetes, comprising infusion, perfusion and injection apparatus and their accessories in the nature of reservoirs, ampoules, adapted bags, bandages for wearing said apparatus; insulin pumps; needle devices in the nature of inserters and insertion needles for mounting cannulas; needles for use with injection or perfusion devices; infusion and perfusion sets suitable to be connected to injection and perfusion devices for self-medication, in particular for treating diabetes; infusion and perfusion tubes suitable for connecting injection and perfusion devices for self-medication, in particular for treating diabetes with respective infusion and perfusion sets; catheters: ampoules for use with injection and perfusion devices for self-medication, in particular for treating diabetes; accessories therefor in the nature of inserters, mounting aids, adapted pouches and bags for transport and storage; medical measuring and control devices in the nature of insulin pumps and devices for self-medication; diabetes monitoring apparatus in the nature of blood glucose meters, all in the field of treating diabetes and diabetes care

Provision of access to information for user of medical instruments and devices for self-medication, particularly diabetes therapies, by means of a global computer information network; providing online information forums and chat rooms for conveyance of news and information in between computer users with regard to medical instruments and devices for self-medication, particularly, diabetes therapies and with regard to health, diet, fitness issues or life style among diabetics and their circle

Scientific and technological services, namely, providing temporary use of online, non-downloadable software for use in performing calculation, evaluation, display, reading and control of medical and diagnostic machines and apparatus for medical and diagnostic purposes, all in the field of treating diabetes and diabetes care

Downloadable or recorded software, particularly calculation, analysis, display, reading and control software, for medical, diagnostic, and medicinal purposes for depicting and analyzing data namely blood glucose values, blood glucose trends versus time, blood glucose target value, current bolus values, bolus history, insulin on board or unused insulin, carbohydrate values, carbohydrate factor, insulin sensitivity factor, duration of insulin action, carbohydrate to insulin factor, calculation and display of meal bolus, calculation and display of correction bolus, calculation and display of insulin stacking, display of bolus suggestion, current basal rate, basal rate profile, basal rate history provided by medical instruments and devices for continuous subcutaneous insulin infusion, namely, insulin pumps, blood glucose meters, and patch pumps; downloadable or recorded software for managing data pertaining to infused insulin and infused insulin history of patients using insulin pumps; downloadable or recorded software for data management of patients using insulin pump, all in the field of treating diabetes and diabetes care

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 13, 2026 GNFN
FINAL REFUSAL E-MAILED
Aug 13, 2026 GNFR
FINAL REFUSAL WRITTEN
Aug 13, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 20, 2026 COAR
CHANGE OF OWNER RECEIVED FROM IB
Jul 2, 2026 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Apr 9, 2026 NREP
REFUSAL PROCESSED BY IB
Feb 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 22, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 22, 2026 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 25, 2025 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 18, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 20, 2025 REPR